← Back to guidelines
Cardiology22 papers

Cerebral atrophy

Last edited: 4/15/2026

Overview

Cerebral atrophy refers to the loss of brain tissue, often leading to cognitive decline and neurological deficits. It can result from various etiologies including neurodegenerative diseases, traumatic brain injury, and developmental disorders. 1 does not directly address cerebral atrophy but highlights the importance of early detection and management of developmental syndromes that may involve neurological assessments.

Diagnosis

  • Neuroimaging (MRI/CT) to visualize brain tissue loss and structural changes 1
  • Cognitive and neurological assessments to evaluate functional impact 1
  • Exclusion of treatable causes through laboratory tests and clinical history 1
  • Management

  • Address underlying causes (e.g., treat infections, manage metabolic disorders) 1
  • Supportive therapies including physical, occupational, and speech therapy 1
  • Symptomatic treatment for associated symptoms (e.g., medications for seizures) 1
  • Special Populations

  • Pediatrics: Early intervention crucial for developmental support 1
  • Elderly: Focus on managing comorbidities and fall prevention to mitigate risks 1
  • Comorbidities: Tailored management plans considering coexisting conditions 1
  • Key Recommendations

  • Conduct comprehensive neuroimaging and cognitive assessments for early detection 1 (Evidence: Moderate)
  • Implement multidisciplinary supportive care including physical and occupational therapy 1 (Evidence: Moderate)
  • Tailor management strategies to address specific underlying causes and comorbidities 1 (Evidence: Expert opinion)
  • References

    1 Judge MR, Misch K, Wright P, Harper JI. Palmoplantar and perioroficial keratoderma with corneal epithelial dysplasia: a new syndrome. The British journal of dermatology 1991. link

    Original source

    1. [1]
      Palmoplantar and perioroficial keratoderma with corneal epithelial dysplasia: a new syndrome.Judge MR, Misch K, Wright P, Harper JI The British journal of dermatology (1991)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG